Autistic disorder. Autistic disorder
Conditions
Interventions
Intervention 1: Intervention group: Cap. ?( 100 BID) plus Risperidone ( 2.5 to 3.5 mg per day) for 10 weeks. Intervention 2: Control group: tablet placebo plus Risperidone( 2.5 to 3.5 mg per day) for
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
11 Years to 17 Years
Inclusion criteria
Inclusion criteria: DSM-5 clinical diagnosis of autistic disorder Teenagers between the ages of 11and 17 years old Presence of behavioral problems such as aggression, overactivity or repetitive behaviors (indication of treatment with risperidone)
Exclusion criteria
Exclusion criteria: Presence of any active medical problem Other psychiatric diagnosis except for mild to moderate Intellectual disability Receiving any antipsychotic medications during past monthprior to the trial Severe hepatic disease History of allergy to risperidone and intolerance of it History of seizure requiring change of antiepileptic dose during the last month Seizure during the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of autism. Timepoint: Baseline and weeks 5, and 10. Method of measurement: By Aberrant Behavior Checklist-Community( ABC-C). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contact????? ?????????
Tehran University of Medical Sciences
Outcome results
None listed